The Syncope Challenge
- Syncope accounts for 3-5% of ED visits and 1-3% of all hospital admissions1,2
- Cardiac syncope carries a 6-month mortality rate of greater than 10%, and doubles the risk of death1
- Syncope negatively impacts patient quality of life3,4
- Diagnosing patients with infrequent symptoms using a conventional Holter monitor is unlikely, due to low symptom-ECG correlation1
Syncope's Impact on Quality of Life3,4
Survival Rates With and Without Syncope1
Unexplained Syncope Patient Selection Considerations
For syncope patients, the fainting frequency and severity of events should be considered when deciding between short-term monitoring with SEEQ MCT and long-term monitoring with Reveal LINQ ICM.
- Soteriades ES, Evans JC, Larson MG, et al. Incidence and prognosis of syncope. N Engl J Med. September 19, 2002; 347(12):878-885.
- Edvardsson N, Frykman V, van Mechelin R, et al. Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registry. Europace. February 2011;13(2):262-269.
- Linzer M, Pontinen M, Gold DT, Divine GW, Felder A, Brooks WB. Impairment of physical and psychosocial function in recurrent syncope. J Clin Epidemiol. 1991;44(10):1037-1043.
- Linzer M, Gold DT, Pontinen M, Divine GW, Felder A, Brooks WB. Recurrent syncope as a chronic disease: preliminary validation of a disease-specific measure of functional impairment. J Gen Int Med. April 1994;9(4):181-186.